PF-Atlas › Clinical Trials › NCT04039087
Sildenafil Exercise: Role of PDE5 Inhibition
Sildenafil 40mg oral capsule · Phase 2
Registry ID
NCT04039087
Phase
Phase 2
Status
Completed
Drug / intervention
Sildenafil 40mg oral capsule
Sponsor
National Jewish Health
Start
2019-09-05
About this trial
Sildenafil 40mg oral capsule is evaluated in NCT04039087, a Phase 2 idiopathic pulmonary fibrosis study sponsored by National Jewish Health. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT04039087 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.